Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced that it has received notification from its licensing partner, Accord Healthcare, that the European Medicines Agency's (EMA) Committee for ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Eric Forrest, best known for his time with Voivod and his ongoing work fronting E-Force, has gone public with his battle against prostate cancer. Earlier today, the Toulouse, France–based vocalist and ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

A stage 4 prostate cancer survivor shares his story of positivity and gratitude. After doing some yard landscaping, I began to have some rather severe back pain and muscle spasms. My first thought was ...

Harry Jowsey revealed he's gotten Botox in his penis during his Boyfriend Material podcast on Tuesday, March 2. The injection ...

As Candel Therapeutics gears up for a planned U.S. approval push for its prostate cancer drug later this year, RTW Investments has stepped in with $100 million to bankroll the launch.

And it costs all of us ...

The REVELUTION (Relugolix versus Leuprolide Cardiac) trial compared coronary plaque after 2 types of androgen deprivation therapy (ADT) for prostate cancer.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Health care prices are on the rise, and patients are flummoxed that even insurance companies aren’t doing more to control costs.

Health care prices are on the rise, and patients are flummoxed that even insurance companies aren’t doing more to control ...